--- title: "Cactus Acquisition Corp. 1 Ltd SEC 10-Q Report" type: "News" locale: "en" url: "https://longbridge.com/en/news/252539550.md" description: "Cactus Acquisition Corp. 1 Ltd has released its Q3 2024 10-Q report, showing a net loss of $78,000 compared to a net gain of $37,000 last year. Earnings per Class A share decreased to $0.08 from $0.13. The company signed a Business Combination Agreement with Tembo e-LV B.V. and was delisted from Nasdaq on November 5, 2024, now trading on the OTC market. The liquidation date has been extended to November 2, 2025, to facilitate the business combination, although concerns about its ongoing viability remain if the deal is not completed." datetime: "2025-08-11T17:53:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/252539550.md) - [en](https://longbridge.com/en/news/252539550.md) - [zh-HK](https://longbridge.com/zh-HK/news/252539550.md) generator: "portal-rs" --- # Cactus Acquisition Corp. 1 Ltd SEC 10-Q Report Cactus Acquisition Corp. 1 Ltd, a company initially focused on technology-based healthcare businesses in Israel and now targeting emerging technology companies globally, particularly in the energy renewables sector, has released its Q3 2024 10-Q report. The report provides a comprehensive overview of the company's financial performance and key business activities during the period. **Financial Highlights** **Net Earnings (Loss) for the Period**: $(78) thousand, reflecting a decrease compared to the previous year's net earnings of $37 thousand. **Basic and Diluted Earnings Per Class A Ordinary Share**: $0.08, compared to $0.13 in the previous year, indicating a decrease in earnings per share. **Basic and Diluted Earnings (Loss) Per Non-Redeemable Class A and Class B Ordinary Shares**: $(0.04), compared to $1.46 in the previous year, showing a significant decrease in earnings per share for non-redeemable shares. **Business Highlights** **Business Combination Agreement**: On August 29, 2024, Cactus Acquisition Corp. 1 Ltd signed a Business Combination Agreement with Tembo e-LV B.V., a private company from the Netherlands. The agreement involves a share exchange and corporate reorganization, with plans to list the new combined company on Nasdaq. **Geographical Focus Shift**: Initially focused on technology-based healthcare businesses in Israel, the company shifted its focus to emerging technology companies globally, particularly in the energy renewables sector, following a change in sponsorship. **Delisting from Nasdaq**: The company was delisted from Nasdaq on November 5, 2024, due to not completing a business combination within the required timeframe. Trading commenced on the OTC market under the symbol CCTSF. **Extension of Combination Period**: The company extended its mandatory liquidation date to November 2, 2025, following shareholder approval. This extension allows more time to complete a business combination. **Future Outlook**: The company is advancing towards completing a business combination with Tembo, with plans to apply for up-listing on Nasdaq post-transaction. However, there is substantial doubt about the company's ability to continue as a going concern if a business combination is not completed by the extended deadline. SEC Filing: Cactus Acquisition Corp. 1 Ltd \[ CCTS \] - 10-Q - Aug. 11, 2025 ### Related Stocks - [CTSUF.US](https://longbridge.com/en/quote/CTSUF.US.md) ## Related News & Research - [Oil set for second weekly rise as unsettled US-Iran war crimps supply](https://longbridge.com/en/news/296555193.md) - [IREN Just Passed Its Biggest AI Test as Microsoft and Nvidia Bet Billions](https://longbridge.com/en/news/296533962.md) - [Trump Boosted INTC and DELL: Now He Says ‘Do Magnets’—Are MP and USAR Stocks Next?](https://longbridge.com/en/news/296591886.md) - [Why Iovance Biotherapeutics Stock Hit 52-Week High](https://longbridge.com/en/news/296522969.md) - [Broadcom Stabilizes After Google's $120 Billion Marvell Shock](https://longbridge.com/en/news/296529317.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**